Literature DB >> 31740487

DOCK2 Sets the Threshold for Entry into the Virtual Memory CD8+ T Cell Compartment by Negatively Regulating Tonic TCR Triggering.

Vinay S Mahajan1,2, Ezana Demissie1, Faisal Alsufyani1,3, Sudha Kumari4, Grace J Yuen1, Vinayak Viswanadham1, Andrew Huang1, Johnson Q Tran5, James J Moon5, Darrell J Irvine1,4, Shiv Pillai6.   

Abstract

The control of cytoskeletal dynamics by dedicator of cytokinesis 2 (DOCK2), a hematopoietic cell-specific actin effector protein, has been implicated in TCR signaling and T cell migration. Biallelic mutations in Dock2 have been identified in patients with a recessive form of combined immunodeficiency with defects in T, B, and NK cell activation. Surprisingly, we show in this study that certain immune functions of CD8+ T cells are enhanced in the absence of DOCK2. Dock2-deficient mice have a pronounced expansion of their memory T cell compartment. Bone marrow chimera and adoptive transfer studies indicate that these memory T cells develop in a cell-intrinsic manner following thymic egress. Transcriptional profiling, TCR repertoire analyses, and cell surface marker expression indicate that Dock2-deficient naive CD8+ T cells directly convert into virtual memory cells without clonal effector T cell expansion. This direct conversion to memory is associated with a selective increase in TCR sensitivity to self-peptide MHC in vivo and an enhanced response to weak agonist peptides ex vivo. In contrast, the response to strong agonist peptides remains unaltered in Dock2-deficient T cells. Collectively, these findings suggest that the regulation of the actin dynamics by DOCK2 enhances the threshold for entry into the virtual memory compartment by negatively regulating tonic TCR triggering in response to weak agonists.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31740487      PMCID: PMC6920543          DOI: 10.4049/jimmunol.1900440

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  DOCK2 is essential for antigen-induced translocation of TCR and lipid rafts, but not PKC-theta and LFA-1, in T cells.

Authors:  Terukazu Sanui; Ayumi Inayoshi; Mayuko Noda; Eiko Iwata; Masahiro Oike; Takehiko Sasazuki; Yoshinori Fukui
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

Review 2.  Alternative memory in the CD8 T cell lineage.

Authors:  You Jeong Lee; Stephen C Jameson; Kristin A Hogquist
Journal:  Trends Immunol       Date:  2011-02-01       Impact factor: 16.687

3.  Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.

Authors:  Kazuhito Gotoh; Yoshihiko Tanaka; Akihiko Nishikimi; Risa Nakamura; Hisakata Yamada; Naoyoshi Maeda; Takahiro Ishikawa; Katsuaki Hoshino; Takehito Uruno; Qinhong Cao; Sadayuki Higashi; Yasushi Kawaguchi; Munechika Enjoji; Ryoichi Takayanagi; Tsuneyasu Kaisho; Yasunobu Yoshikai; Yoshinori Fukui
Journal:  J Exp Med       Date:  2010-03-15       Impact factor: 14.307

4.  Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis.

Authors:  Akihiko Nishikimi; Hideo Fukuhara; Wenjuan Su; Tsunaki Hongu; Shunsuke Takasuga; Hisashi Mihara; Qinhong Cao; Fumiyuki Sanematsu; Motomu Kanai; Hiroshi Hasegawa; Yoshihiko Tanaka; Masakatsu Shibasaki; Yasunori Kanaho; Takehiko Sasaki; Michael A Frohman; Yoshinori Fukui
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

5.  Compendium of Immune Signatures Identifies Conserved and Species-Specific Biology in Response to Inflammation.

Authors:  Jernej Godec; Yan Tan; Arthur Liberzon; Pablo Tamayo; Sanchita Bhattacharya; Atul J Butte; Jill P Mesirov; W Nicholas Haining
Journal:  Immunity       Date:  2016-01-12       Impact factor: 31.745

6.  Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion.

Authors:  Saïdi M'Homa Soudja; Anne L Ruiz; Julien C Marie; Grégoire Lauvau
Journal:  Immunity       Date:  2012-08-30       Impact factor: 31.745

Review 7.  CD69: from activation marker to metabolic gatekeeper.

Authors:  Danay Cibrián; Francisco Sánchez-Madrid
Journal:  Eur J Immunol       Date:  2017-06       Impact factor: 5.532

8.  Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells.

Authors:  Mohammad Rashidian; Jessica R Ingram; Michael Dougan; Anushka Dongre; Katherine A Whang; Camille LeGall; Juan J Cragnolini; Brian Bierie; Monica Gostissa; James Gorman; Gijsbert M Grotenbreg; Atul Bhan; Robert A Weinberg; Hidde L Ploegh
Journal:  J Exp Med       Date:  2017-06-30       Impact factor: 14.307

9.  The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion.

Authors:  Catherine Haluszczak; Adovi D Akue; Sara E Hamilton; Lisa D S Johnson; Lindsey Pujanauski; Lenka Teodorovic; Stephen C Jameson; Ross M Kedl
Journal:  J Exp Med       Date:  2009-02-02       Impact factor: 14.307

10.  CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity.

Authors:  H S Azzam; A Grinberg; K Lui; H Shen; E W Shores; P E Love
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  4 in total

1.  T Cell Reprogramming Against Cancer.

Authors:  Samuel G Katz; Peter M Rabinovich
Journal:  Methods Mol Biol       Date:  2020

Review 2.  Functional heterogeneity and adaptation of naive T cells in response to tonic TCR signals.

Authors:  Joel Eggert; Byron B Au-Yeung
Journal:  Curr Opin Immunol       Date:  2021-10-12       Impact factor: 7.486

Review 3.  Signals for antigen-independent differentiation of memory CD8+ T cells.

Authors:  Eliza Mari Kwesi-Maliepaard; Heinz Jacobs; Fred van Leeuwen
Journal:  Cell Mol Life Sci       Date:  2021-08-16       Impact factor: 9.261

Review 4.  Insights from DOCK2 in cell function and pathophysiology.

Authors:  Lulin Ji; Shuquan Xu; Haiqing Luo; Fanwei Zeng
Journal:  Front Mol Biosci       Date:  2022-09-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.